Drugs
Home
Search
Alphabetical
By Drug Class
Approval Status:
FDA-Approved
Investigational
Combination Drugs
Atripla
Combivir
Complera
Epzicom
Kaletra
Stribild
Trizivir
Truvada
Entry and Fusion Inhibitors
Enfuvirtide
Maraviroc
Integrase Inhibitors
Raltegravir
Non-nucleoside Reverse Transcriptase Inhibitors
Delavirdine
Efavirenz
Etravirine
Nevirapine
Rilpivirine
Nucleoside Reverse Transcriptase Inhibitors
Abacavir
Abacavir / Lamivudine
Abacavir / Lamivudine / Zidovudine
Didanosine
Emtricitabine
Emtricitabine / Tenofovir Disoproxil Fumarate
Lamivudine
Lamivudine / Zidovudine
Stavudine
Tenofovir Disoproxil Fumarate
Zidovudine
Opportunistic Infections
Acyclovir
Albendazole
Amphotericin B
Azithromycin
Boceprevir
Butoconazole Nitrate
Ciprofloxacin
Clarithromycin
Clindamycin
Clotrimazole
Ethambutol Hydrochloride
Famciclovir
Fluconazole
Flucytosine
Foscarnet Sodium
Ganciclovir
Hepatitis A and Hepatitis B (Recombinant) Vaccine
Hepatitis B Vaccine
Imiquimod
Isoniazid
Itraconazole
Levofloxacin
Miconazole
Moxifloxacin Hydrochloride
Peginterferon Alfa-2a
Peginterferon Alfa-2b
Primaquine Phosphate
Pyrazinamide
Pyrimethamine
Ribavirin
Rifabutin
Rifampin
Sulfadiazine
Sulfamethoxazole / Trimethoprim
Telaprevir
Terconazole
Valacyclovir Hydrochloride
Valganciclovir Hydrochloride
Varicella Virus Vaccine Live
Voriconazole
Protease Inhibitors
Atazanavir
Darunavir
Fosamprenavir
Indinavir
Lopinavir / Ritonavir
Nelfinavir
Ritonavir
Saquinavir
Tipranavir
Entry and Fusion Inhibitors
AMD-070
BMS-663068
Cenicriviroc
Ibalizumab
INCB-9471
PRO-140
Integrase Inhibitors
Dolutegravir
Elvitegravir
S/GSK1265744
Non-nucleoside Reverse Transcriptase Inhibitors
Lersivirine
Nucleoside Reverse Transcriptase Inhibitors
BMS-986001
Elvucitabine
Racivir
Tenofovir Alafenamide
Facebook
Twitter